Australian Prostate Cancer was established to assist with the funding of vital medical research into the detection and treatment of prostate cancer, as well as preventing the metastatic spread of the disease.

Prostate cancer is the most common form of internal cancer in Australia with 1 in 4 men at risk of developing prostate cancer in their lifetime.

In 2008 more than 20,750 new cases of prostate cancer were diagnosed in Australia and 3,000 men died from the disease. Each year prostate cancer claims more men’s lives in this country than breast cancer does in women.

Australian Prostate Cancer (APC) is a disease specific affiliate of  The Hospital Research Foundation (THRF). Donations to Australian Prostate Cancer are directed specifically at research into prostate cancer.

To find out more about APC visit the website

APCR logo

Find out more about Australian Prostate Cancer